BPPDA_BOTCO
ID BPPDA_BOTCO Reviewed; 13 AA.
AC P0DKZ6;
DT 03-APR-2013, integrated into UniProtKB/Swiss-Prot.
DT 03-APR-2013, sequence version 1.
DT 29-SEP-2021, entry version 17.
DE RecName: Full=Bradykinin-potentiating peptide 13a {ECO:0000303|PubMed:22869554};
DE Short=BPP-13a {ECO:0000303|PubMed:22869554};
OS Bothrops cotiara (Cotiara) (Rhinocerophis cotiara).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC Serpentes; Colubroidea; Viperidae; Crotalinae; Bothrops.
OX NCBI_TaxID=8727;
RN [1]
RP PROTEIN SEQUENCE, FUNCTION, PYROGLUTAMATE FORMATION AT GLN-1, MASS
RP SPECTROMETRY, AND SUBCELLULAR LOCATION.
RC TISSUE=Venom;
RX PubMed=22869554; DOI=10.1074/mcp.m112.019331;
RA Tashima A.K., Zelanis A., Kitano E.S., Ianzer D., Melo R.L., Rioli V.,
RA Sant'anna S.S., Schenberg A.C., Camargo A.C., Serrano S.M.T.;
RT "Peptidomics of three Bothrops snake venoms: insights into the molecular
RT diversification of proteomes and peptidomes.";
RL Mol. Cell. Proteomics 11:1245-1262(2012).
CC -!- FUNCTION: This peptide both inhibits the activity of the angiotensin-
CC converting enzyme (ACE) and enhances the action of bradykinin by
CC inhibiting the peptidases that inactivate it. It acts as an indirect
CC hypotensive agent (By similarity). {ECO:0000250,
CC ECO:0000269|PubMed:22869554}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:22869554}.
CC -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC {ECO:0000305|PubMed:22869554}.
CC -!- MASS SPECTROMETRY: Mass=1369.7; Method=Electrospray;
CC Evidence={ECO:0000269|PubMed:22869554};
CC -!- SIMILARITY: Belongs to the bradykinin-potentiating peptide family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0008191; F:metalloendopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR GO; GO:0008217; P:regulation of blood pressure; IEA:UniProtKB-KW.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Hypotensive agent; Metalloenzyme inhibitor;
KW Metalloprotease inhibitor; Protease inhibitor; Pyrrolidone carboxylic acid;
KW Secreted; Toxin.
FT PEPTIDE 1..13
FT /note="Bradykinin-potentiating peptide 13a"
FT /evidence="ECO:0000269|PubMed:22869554"
FT /id="PRO_0000421906"
FT MOD_RES 1
FT /note="Pyrrolidone carboxylic acid"
FT /evidence="ECO:0000269|PubMed:22869554"
FT UNSURE 11
FT /note="I or L"
FT /evidence="ECO:0000305"
SQ SEQUENCE 13 AA; 1388 MW; 6824FC97D83D6774 CRC64;
QGGWPRPGPE IPP